CANTOR FITZGERALD, L. P. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CANTOR FITZGERALD, L. P. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$26,030
+17.2%
363,5480.0%0.00%0.0%
Q2 2023$22,213
+52.4%
363,5480.0%0.00%
Q1 2023$14,578
+91012.5%
363,5480.0%0.00%
Q4 2022$16
-99.9%
363,5480.0%0.00%
-100.0%
Q3 2022$29,000
-19.4%
363,5480.0%0.00%0.0%
Q2 2022$36,000
-54.4%
363,5480.0%0.00%
-83.3%
Q1 2022$79,000
-50.0%
363,548
-3.1%
0.01%
-45.5%
Q4 2021$158,000375,0000.01%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,636,0000.09%
Telemetry Investments, L.L.C. 121,614$23,0000.04%
Radcliffe Capital Management, L.P. 150,000$1,501,0000.03%
Q Global Advisors, LLC 170,785$37,0000.02%
CANTOR FITZGERALD, L. P. 363,548$79,0000.01%
Atalaya Capital Management LP 225,000$50,0000.01%
MMCAP International Inc. SPC 375,000$82,0000.01%
Bulldog Investors, LLP 54,745$11,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 108,741$24,0000.00%
Context Capital Management, LLC 200,000$44,0000.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders